Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder
- PMID: 12747884
- DOI: 10.1016/S0140-6736(03)13266-7
Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder
Abstract
Transient myeloid disorder is a unique self-regressing neoplasia specific to Down's syndrome. The transcription factor GATA1 is needed for normal growth and maturation of erythroid cells and megakaryocytes. Mutations in GATA1 have been reported in acute megakaryoblastic leukaemia in Down's syndrome. We aimed to investigate changes in GATA1 in patients with Down's syndrome and either transient myeloid disorder (n=10) or acute megakaryoblastic leukaemia (n=6). We recorded mutations eliminating exon 2 from GATA1 in all patients with transient myeloid disorder (age 0-24 days) and in all with acute megakaryoblastic leukaemia (age 14-38 months). The range of mutations did not differ between patients with each disorder. Patients with transient myeloid disorder with mutations in GATA1 can regress spontaneously to complete remission, and mutations do not necessarily predict later acute megakaryoblastic leukaemia.
Similar articles
-
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.Blood. 2003 Aug 1;102(3):981-6. doi: 10.1182/blood-2002-11-3599. Epub 2003 Mar 20. Blood. 2003. PMID: 12649131
-
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.Lancet. 2008 Oct 25;372(9648):1484-92. doi: 10.1016/S0140-6736(08)61341-0. Epub 2008 Sep 19. Lancet. 2008. PMID: 18805579
-
Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.Br J Haematol. 1995 Jul;90(3):607-14. doi: 10.1111/j.1365-2141.1995.tb05591.x. Br J Haematol. 1995. PMID: 7647001
-
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.Blood. 2004 Jan 15;103(2):399-406. doi: 10.1182/blood-2003-05-1556. Epub 2003 Sep 25. Blood. 2004. PMID: 14512321 Review.
-
Origins of leukaemia in children with Down syndrome.Nat Rev Cancer. 2005 Jan;5(1):11-20. doi: 10.1038/nrc1525. Nat Rev Cancer. 2005. PMID: 15630411 Review.
Cited by
-
Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view.Expert Rev Mol Med. 2021 Apr 27;23:e5. doi: 10.1017/erm.2021.6. Expert Rev Mol Med. 2021. PMID: 33902785 Free PMC article.
-
Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.J Biomed Res. 2010 Mar;24(2):87-99. doi: 10.1016/S1674-8301(10)60016-4. J Biomed Res. 2010. PMID: 23554618 Free PMC article.
-
GATA transcription factors in hematologic disease.Int J Hematol. 2005 Jun;81(5):378-84. doi: 10.1532/ijh97.04180. Int J Hematol. 2005. PMID: 16158817 Review.
-
The impact of trisomy 21 on foetal haematopoiesis.Blood Cells Mol Dis. 2013 Dec;51(4):277-81. doi: 10.1016/j.bcmd.2013.07.008. Epub 2013 Aug 7. Blood Cells Mol Dis. 2013. PMID: 23932236 Free PMC article. Review.
-
Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome.Leukemia. 2020 Aug;34(8):1984-1999. doi: 10.1038/s41375-020-0854-5. Epub 2020 May 20. Leukemia. 2020. PMID: 32433508 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
